Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 14.7M | $ 4.78M | 32.49% |
3/31/2025 | $ 7.18M | $ 6.12M | 85.22% |
12/31/2024 | $ 7.57M | $ 7.16M | 94.69% |
9/30/2024 | $ 9.21M | $ 8.48M | 92.11% |
6/30/2024 | $ 13.91M | $ 16.04M | 115.31% |
3/31/2024 | $ 8.91M | $ 15.35M | 172.27% |
12/31/2023 | $ 5.12M | $ 14.38M | 280.56% |
9/30/2023 | $ 3.2M | $ 13.47M | 420.47% |
6/30/2023 | $ 8.61M | $ 5.22M | 60.68% |
3/31/2023 | $ 8.64M | $ 4.76M | 55.14% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for VERRICA PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 4.28M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |